Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
64x Bio logo — Enabling next generation medicines.

64x Bio

Enabling next generation medicines.

Founded 2018 United States Brisbane, United States 21 employees Series A Total: $59.50M Biopharma, Biotechnology +2

General Information

Company Name 64x Bio
Founded Year 2018
Location United States Brisbane, United States +1
Employees 21
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Series A
Social

Get notified when 64x Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About 64x Bio

64x Bio, founded in 2018 and headquartered in the United States, positions itself at the forefront of the life sciences industry with its mission of "Enabling next generation medicines." The company provides a sophisticated platform and product suite specifically tailored for advanced therapeutics, capturing attention in the intersecting sectors of Biopharma, Biotechnology, Life Sciences, and Pharmaceuticals.

The company secured a substantial $55.00M Series A investment on 19 January 2022, which underscores investor confidence in its growth potential and innovative capabilities. This financing round included prominent investors such as BoxGroup, First Round Capital, Liquid 2 Ventures, and Northpond Ventures, among others. The involvement of seasoned investors like Michael Chambers, Chris Gibson, and Milad Alucozai further validates the company's strategic direction and technological promise.

Taxonomy: Mammalian Cell Line Discovery, High Throughput Screening, Computational Design Loop, Viral Vector Manufacturing, Cell and Gene Therapy, Gene Therapy, Synthetic Biology, Genome Engineering, Functional Genomics, Biopharmaceutical Innovation, Advanced Therapeutics, Biomanufacturing Optimization, Therapeutic Cell Lines, Biotechnology R&D

Services & Products

Engineering high yield cell lines
Optimizing production technologies
Gene therapy manufacturing
Cell line licensing
Therapeutic system design

Target Customers

Biopharmaceutical Companies Contract Development and Manufacturing Organizations (CDMOs) Biotech Researchers Gene Therapy Developers Cell and Gene Therapy Companies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		19 Jan 2022
Seed Round •••••• - 16 Nov 2020
Seed Round •••••• - 20 Aug 2018

64x Bio Alternatives & Competitors

View All Alternatives
64x Bio vs
EditCo Bio
EditCo Bio United States

Rewriting the future of discoveries

77 employees
64x Bio vs
Namocell
Namocell United States

The Fastest Way to Single Cells

Series A
8 employees
Biotechnology, Life Sciences
64x Bio vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About 64x Bio

Enabling next generation medicines.
64x Bio was founded in 2018.
64x Bio is headquartered in Brisbane, United States.
64x Bio operates in the following industries: Biopharma, Biotechnology, Life Sciences, Pharmaceutical.
64x Bio has approximately 21 employees.
64x Bio has completed 3 funding rounds, raising a total of $59.50M. The latest funding stage is Series A.
64x Bio offers: Engineering high yield cell lines, Optimizing production technologies, Gene therapy manufacturing, Cell line licensing, Therapeutic system design.
Top alternatives and competitors to 64x Bio include EditCo Bio, Namocell, RoslinCT, Indee Labs, Horizon Discovery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
64x Bio and EditCo Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors 64x Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy